AR069740A1 - Compuestos nucleosidos antivirales - Google Patents
Compuestos nucleosidos antiviralesInfo
- Publication number
- AR069740A1 AR069740A1 ARP080105126A ARP080105126A AR069740A1 AR 069740 A1 AR069740 A1 AR 069740A1 AR P080105126 A ARP080105126 A AR P080105126A AR P080105126 A ARP080105126 A AR P080105126A AR 069740 A1 AR069740 A1 AR 069740A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- pyridinyl
- heteroaryl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
Son inhibidores de la polimerasa NS5b del virus de la hepatitis C. También se describen composiciones y métodos para el tratamiento de una infeccion por VHC y que inhiben la replicacion de VHC3. Reivindicacion 1: Un compuesto con la formula general (1) o (2) en el que y es fenilo o piridinilo, estando dicho fenilo o piridinilo opcionalmente sustituido con uno a tres sustituyentes seleccionado de entre el grupo que consiste en halogeno, alquilo C1-6, haloalquilo C1-6, alcoxi C1-6, o ciano; B es (B-1), (B-2) o (B-3); R1 y R2 se seleccionan independientemente a partir de H y/o COR4; Y es O o NH; R3 es alquilo C1-6 o COR4 y, R4 es alquilo C1-6, alcoxi C1-3 alquilo -C1-6, cicloalquilo C3-6, cicloalquil C3-6 alquilo -C1-3, alcoxi C1-6 o heteroarilo en la que el heteroarilo es un anillo de cinco miembros que contiene uno o dos heteroátomos seleccionados de nitrogeno, oxígeno o azufre o piridina o un anillo de seis miembros con uno o dos átomos de nitrogeno; o, una sal farmacéuticamente aceptable de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99116307P | 2007-11-29 | 2007-11-29 | |
US8454408P | 2008-07-29 | 2008-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR069740A1 true AR069740A1 (es) | 2010-02-17 |
Family
ID=40679083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080105126A AR069740A1 (es) | 2007-11-29 | 2008-11-26 | Compuestos nucleosidos antivirales |
Country Status (20)
Country | Link |
---|---|
US (2) | US8063025B2 (es) |
EP (1) | EP2227481A4 (es) |
JP (1) | JP2011505351A (es) |
KR (1) | KR20100103793A (es) |
CN (1) | CN102164939A (es) |
AR (1) | AR069740A1 (es) |
AU (1) | AU2008331158A1 (es) |
BR (1) | BRPI0819797A2 (es) |
CA (1) | CA2706432A1 (es) |
CL (1) | CL2008003511A1 (es) |
CO (1) | CO6382185A2 (es) |
CR (1) | CR11453A (es) |
EC (1) | ECSP10010210A (es) |
IL (1) | IL205625A0 (es) |
MA (1) | MA31864B1 (es) |
MX (1) | MX2010005885A (es) |
RU (1) | RU2010126050A (es) |
TW (1) | TW200936146A (es) |
WO (1) | WO2009069095A2 (es) |
ZA (1) | ZA201003438B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2525237T3 (es) | 2007-11-29 | 2014-12-19 | Boehringer Ingelheim International Gmbh | Derivados de amidas del ácido 6,7-dihidro-5H-imidazo[1,2-a]imidazol-3-carboxílico |
RU2556991C2 (ru) * | 2010-01-28 | 2015-07-20 | Рибосайенс Ллк | 4'-азидонуклеозиды, активные в отношении hcv |
WO2012040124A1 (en) | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
WO2012075140A1 (en) | 2010-11-30 | 2012-06-07 | Pharmasset, Inc. | Compounds |
WO2013070887A1 (en) * | 2011-11-10 | 2013-05-16 | Inhibitex, Inc. | Substituted purine nucleosides, phosphoramidate and phosphordiamidate derivatives for treatment of viral infections |
WO2015077368A1 (en) | 2013-11-22 | 2015-05-28 | Ligand Pharmaceuticals Incorporated | Derivatives of uridine 5'-cyclophosphate useful to treat hepatitis c viral infections |
CN103848877B (zh) * | 2013-12-16 | 2016-08-24 | 安徽贝克联合制药有限公司 | 核苷环磷酸酯化合物及其制备方法和其应用 |
AU2015217221A1 (en) | 2014-02-13 | 2016-08-11 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
CN106687118A (zh) | 2014-07-02 | 2017-05-17 | 配体药物公司 | 前药化合物及其用途 |
JP6949002B6 (ja) | 2015-08-05 | 2021-11-17 | メトロ インターナショナル バイオテック,エルエルシー | ニコチンアミドモノヌクレオチド誘導体及びそれらの使用 |
WO2018129040A1 (en) | 2017-01-04 | 2018-07-12 | President And Fellows Of Harvard College | Modulating nudix homology domain (nhd) with nicotinamide mononucleotide analogs and derivatives of same |
CN108727450B (zh) * | 2017-04-18 | 2024-02-20 | 浙江柏拉阿图医药科技有限公司 | 肝递送抗丙肝前体药物核苷环磷酸酯化合物及应用 |
CN109956975B (zh) * | 2017-12-22 | 2020-11-06 | 浙江柏拉阿图医药科技有限公司 | 肝递送恩替卡韦前体药物核苷环磷酸酯化合物及应用 |
CN109956985A (zh) * | 2017-12-22 | 2019-07-02 | 浙江柏拉阿图医药科技有限公司 | 肝递送阿糖胞苷前体药物核苷环磷酸酯化合物及应用 |
CN109956986B (zh) * | 2017-12-22 | 2021-04-27 | 浙江柏拉阿图医药科技有限公司 | 肝递送吉西他滨前体药物核苷环磷酸酯化合物及应用 |
EP3737676B1 (en) | 2018-01-09 | 2024-03-06 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
CN111434671B (zh) * | 2019-01-11 | 2023-07-11 | 凯思凯迪(上海)医药科技有限公司 | 肝脏特异性ampk激动剂及其制法和应用 |
TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
US11697666B2 (en) | 2021-04-16 | 2023-07-11 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4741725B2 (ja) * | 1998-03-06 | 2011-08-10 | メタベイシス・セラピューティクス・インコーポレーテッド | リン含有化合物のための新規なプロドラッグ |
GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
WO2004041834A2 (en) | 2002-10-31 | 2004-05-21 | Metabasis Therapeutics, Inc. | Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
TWI332507B (en) * | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
WO2005009418A2 (en) | 2003-07-25 | 2005-02-03 | Idenix (Cayman) Limited | Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c |
EP1781101A2 (en) | 2004-07-29 | 2007-05-09 | Metabasis Therapeutics, Inc. | Novel nucleoside derivatives |
WO2007020193A2 (en) * | 2005-08-15 | 2007-02-22 | F. Hoffmann-La Roche Ag | Antiviral phosphoramidates of 4 ' -substituted pronucleotides |
JP4954573B2 (ja) * | 2006-02-28 | 2012-06-20 | オリンパス株式会社 | 内視鏡システム |
-
2008
- 2008-11-26 AR ARP080105126A patent/AR069740A1/es not_active Application Discontinuation
- 2008-11-26 CL CL2008003511A patent/CL2008003511A1/es unknown
- 2008-11-26 TW TW097145866A patent/TW200936146A/zh unknown
- 2008-11-26 US US12/313,992 patent/US8063025B2/en active Active
- 2008-11-27 MX MX2010005885A patent/MX2010005885A/es not_active Application Discontinuation
- 2008-11-27 WO PCT/IB2008/054985 patent/WO2009069095A2/en active Application Filing
- 2008-11-27 KR KR1020107011589A patent/KR20100103793A/ko not_active Application Discontinuation
- 2008-11-27 EP EP08855731A patent/EP2227481A4/en not_active Withdrawn
- 2008-11-27 CA CA2706432A patent/CA2706432A1/en not_active Abandoned
- 2008-11-27 BR BRPI0819797A patent/BRPI0819797A2/pt not_active IP Right Cessation
- 2008-11-27 CN CN2008801185991A patent/CN102164939A/zh active Pending
- 2008-11-27 JP JP2010535494A patent/JP2011505351A/ja active Pending
- 2008-11-27 AU AU2008331158A patent/AU2008331158A1/en not_active Abandoned
- 2008-11-27 RU RU2010126050/04A patent/RU2010126050A/ru not_active Application Discontinuation
-
2010
- 2010-05-09 IL IL205625A patent/IL205625A0/en unknown
- 2010-05-13 CO CO10057513A patent/CO6382185A2/es not_active Application Discontinuation
- 2010-05-14 ZA ZA2010/03438A patent/ZA201003438B/en unknown
- 2010-05-21 CR CR11453A patent/CR11453A/es not_active Application Discontinuation
- 2010-05-27 MA MA32870A patent/MA31864B1/fr unknown
- 2010-05-28 EC EC2010010210A patent/ECSP10010210A/es unknown
-
2011
- 2011-10-26 US US13/282,100 patent/US20120039845A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL205625A0 (en) | 2010-11-30 |
CN102164939A (zh) | 2011-08-24 |
US20090209481A1 (en) | 2009-08-20 |
AU2008331158A1 (en) | 2009-06-04 |
CL2008003511A1 (es) | 2010-02-19 |
EP2227481A4 (en) | 2011-03-09 |
RU2010126050A (ru) | 2012-01-10 |
BRPI0819797A2 (pt) | 2019-09-24 |
US20120039845A1 (en) | 2012-02-16 |
CA2706432A1 (en) | 2009-06-04 |
CO6382185A2 (es) | 2012-02-15 |
MX2010005885A (es) | 2010-11-24 |
JP2011505351A (ja) | 2011-02-24 |
ZA201003438B (en) | 2011-04-28 |
ECSP10010210A (es) | 2010-08-31 |
US8063025B2 (en) | 2011-11-22 |
TW200936146A (en) | 2009-09-01 |
EP2227481A2 (en) | 2010-09-15 |
KR20100103793A (ko) | 2010-09-28 |
CR11453A (es) | 2010-10-27 |
WO2009069095A3 (en) | 2009-12-23 |
MA31864B1 (fr) | 2010-11-01 |
WO2009069095A2 (en) | 2009-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR069740A1 (es) | Compuestos nucleosidos antivirales | |
EA200800476A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
EA200970493A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
AR085615A1 (es) | Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen | |
CO6160231A2 (es) | Compuestos de isoindolina 5-substituidos | |
AR082696A1 (es) | Derivados heterociclicos nitrogenados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades cardiovasculares e inflamatorias, entre otras | |
CO6251247A2 (es) | Imidazoquinolinas con propiedades inmuno-moduladoras | |
ES2570127T3 (es) | Compuestos y composiciones como inhibidores de la proteína quinasa | |
AR057703A1 (es) | INHIBIDORES MACROCíCLICOS DEL VIRUS DE LA HEPATITIS C. PROCESO DE PREPARACIoN Y COMPOSICIONES FARMACÉUTICAS. | |
AR054882A1 (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
RU2012140961A (ru) | ПРОИЗВОДНОЕ 1,3,4,8-ТЕТРАГИДРО-2Н-ПИРИДО[1,2-a]ПИРАЗИНА И ЕГО ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНИБИТОРА ИНТЕГРАЗЫ ВИЧ | |
AR079231A1 (es) | Derivados de imidazoquinolina | |
AR084588A1 (es) | Compuesto heterociclico fusionado y su uso para el control de plagas | |
CO6251260A2 (es) | Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c. | |
ES2613538T3 (es) | Derivados de arilamida como bloqueadores de TTX-S | |
AR070361A1 (es) | Compuestos heterociclicos antiviricos | |
AR076579A1 (es) | Espironucleosidos uracilicos oxetanicos, composiciones farmaceuticas que los contienen y uso de los mismos como inhibidores del virus de la hepatitis c (vhc). | |
AR056327A1 (es) | Compuestos de nucleosidos para el tratamiento de infecciones virales | |
JP2008525417A5 (es) | ||
JP2010077137A5 (es) | ||
CO5700780A2 (es) | Derivados de quinolina como inhibidores, selectivos, de de fosfodiesterasa pde 4b | |
AR047056A1 (es) | Derivados de pirimidinas condensadas. composiciones farmacéuticas | |
AR074109A1 (es) | Pirrolidinas heterociclicas agonistas de receptores de la melanocortina, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento de la obesidad, diabetes y disfuncion erectil. | |
AR056445A1 (es) | Derivados arilicos y heteroarilicos de 6 miembros para tratar virus | |
AR074504A1 (es) | Nucleotidos uracil ciclopropilicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |